UCSF

ZINC00012346

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 15 No

Other Names:

(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

(+/-)-3TC

(+/-)-BCH-189

(+/-)-SddC

(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)NGPB-21; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hyd

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-2'-Deoxy-3'-thiacytidine; 3'-Thia-2',3'-dideoxycytidine; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine

(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl]Cytosine

(-)-2'-Deoxy-3'-thiacytidine

(-)-BCH 189

(-)-BCH-189

(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine

(-)-SddC

(-)NGPB-21

(2R, 5S) -2-(Hydroxymethyl)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane salicylate

(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one

(2R,cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl])-(1H)pyrimidin-2-one

vudine

.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To

134678-17-4

134678-17-4; 2',3'-Dideoxy-3'-thiacytidine; 3TC; C07065; Lamivudine

134678-17-4; D00353; Epivir (TN); Lamivudine (JAN/USP/INN)

2',3' Dideoxy 3' thiacytidine

2',3'-Dideoxy-3'-thiacytidine

2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-

2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-

2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)

2_,3_-Dideoxy-3_-thiacytidine

3'-Thia-2',3'-dideoxycytidine

3TC

3TC & GNA

3TC & SST

3TC (AIDS INITIATIVE) (AIDS INITIATIVE)

3TC and NV-01

3TC, Zeffix, Heptovir, Epivir, Epivir-HBV

3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine

4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone

4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one

4-Amino-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one

4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one

4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one

480434-79-5

AC-1416

AC1L1TZZ

AC1Q6C34

BAN

BCH 189

BCH 189, (-)-

BCH-189

BCH-790

BCH189

beta-L-2',3'-Dideoxy-3'-thiacytidine

beta-L-3'-Thia-2',3'-dideoxycytidine

BIDD:GT0033

Bio-0652

C07065

C8H11N3O3S

CCRIS 9274

CHEBI:133986

CHEBI:6366

CHEMBL141

CID60825

CPD000466319

CPD000466319; LAMIVUDINE

CPD000466319; LAMIVUDINE; SAM001246582

CPD000466319; LAMIVUDINE; SAM002589994

D00353

D019259

DAP000167

DB00709

DRG-0126

DTHC

Epivir

Epivir (TN)

Epivir(TM)

Epivir-HBV

Epivir

FDA

FT-0082667

GG-714

GR 109714X

GR-109714X

GR109714X

Hepitec

Heptivir

Heptodin

Heptovir

HHA & 3TC

HHA & Lamivudine

HMS2051D21

HSDB 7155

INN

L0217

Lamivir

Lamivudine & GNA

Lamivudine (BAN

Lamivudine (Epivir)

Lamivudine (FDA

Lamivudine (JAN/USP/INN)

Lamivudine salicylate

Lamivudine [Usan:Ban:Inn]

Lamivudine [USAN:INN:BAN]

Lamivudine, (2S-cis)-Isomer

LMV

LS-2107

MFCD00869739

MFCD09751000

MLS000759424

MLS001424097

MolPort-002-507-347

NCGC00159341-03

NCGC00159341-04

NSC620753

QA-4615

S1706_Selleck

SAM001246582

SAM002589994

SMR000466319

STK801940

UNII-2T8Q726O95

USAN

USP)

Zeffix

Zefix

ZINC00012346

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -1.09 -2.17 -16.53 3 6 0 90 229.261 2

Vendor Notes

Note Type Comments Provided By
MP 177 TCI
ALOGPS_SOLUBILITY 2.76e+00 g/l DrugBank-approved
Purity 95% Fluorochem
biological_use Active against hepatitis B virus and human immunodeficiency virus IBScreen Bioactives
Indications antiviral KeyOrganics Bioactives
UniProt Database Links DPOL_ASHV; DPOL_GSHV; DPOL_HBVA2; DPOL_HBVA3; DPOL_HBVA4; DPOL_HBVA5; DPOL_HBVA6; DPOL_HBVA7; DPOL_HBVA8; DPOL_HBVA9; DPOL_HBVB1; DPOL_HBVB2; DPOL_HBVB3; DPOL_HBVB4; DPOL_HBVB5; DPOL_HBVB6; DPOL_HBVB7; DPOL_HBVB8; DPOL_HBVC0; DPOL_HBVC1; DPOL_HBVC2; DPOL_ ChEBI
Indications hepatitis B, HIV KeyOrganics Bioactives
mechanism HIV reverse transcriptase inhibitor IBScreen Bioactives
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : L-9512; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE TO CREAM COLORED POWDER NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01125l NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
biological_use Potent antiviral agent IBScreen Bioactives IBScreen Bioactives
Target Reverse Transcriptase Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: L-9512; SUPPLIER_COMMENTS: WHITE TO CREAM COLORED POWDER NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01125l NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
Z100081-1-O PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other Other 27 0.71 Functional ≤ 10μM
Z101829-1-O HBV Genotype D (cluster #1 Of 1), Other Other 460 0.59 Functional ≤ 10μM
Z50518-3-O Human Herpesvirus 4 (cluster #3 Of 5), Other Other 400 0.60 Functional ≤ 10μM
Z50602-2-O Human Herpesvirus 1 (cluster #2 Of 5), Other Other 2200 0.53 Functional ≤ 10μM
Z50606-1-O Hepatitis B Virus (cluster #1 Of 3), Other Other 81 0.66 Functional ≤ 10μM
Z50607-1-O Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other Other 969 0.56 Functional ≤ 10μM
Z50658-1-O Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other Other 2000 0.53 Functional ≤ 10μM
Z50677-1-O Human Immunodeficiency Virus (cluster #1 Of 3), Other Other 60 0.67 Functional ≤ 10μM
Z50681-1-O Duck Hepatitis B Virus (cluster #1 Of 2), Other Other 44 0.69 Functional ≤ 10μM
Z50755-1-O Anas Sp. (cluster #1 Of 1), Other Other 100 0.65 Functional ≤ 10μM
Z80295-2-O MT4 (Lymphocytes) (cluster #2 Of 8), Other Other 7000 0.48 Functional ≤ 10μM
Z80947-1-O Hepatoblastoma Cell Line (cluster #1 Of 1), Other Other 70 0.67 Functional ≤ 10μM
Z80949-1-O Hepatoma Cell Line (cluster #1 Of 1), Other Other 10 0.75 Functional ≤ 10μM
Z81020-1-O HepG2 (Hepatoblastoma Cells) (cluster #1 Of 8), Other Other 8 0.76 Functional ≤ 10μM
Q72547-1-V Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral Viruses 42 0.69 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Q72547_9HIV1 Q72547 Human Immunodeficiency Virus Type 1 Reverse Transcriptase, 9hiv1 42 0.69 Binding ≤ 1μM
Q72547_9HIV1 Q72547 Human Immunodeficiency Virus Type 1 Reverse Transcriptase, 9hiv1 42 0.69 Binding ≤ 10μM
Z50755 Z50755 Anas Sp. 100 0.65 Functional ≤ 10μM
Z50681 Z50681 Duck Hepatitis B Virus 40 0.69 Functional ≤ 10μM
Z101829 Z101829 HBV Genotype D 30 0.70 Functional ≤ 10μM
Z50606 Z50606 Hepatitis B Virus 100 0.65 Functional ≤ 10μM
Z80947 Z80947 Hepatoblastoma Cell Line 70 0.67 Functional ≤ 10μM
Z80949 Z80949 Hepatoma Cell Line 10 0.75 Functional ≤ 10μM
Z81020 Z81020 HepG2 (Hepatoblastoma Cells) 200 0.63 Functional ≤ 10μM
Z50602 Z50602 Human Herpesvirus 1 2200 0.53 Functional ≤ 10μM
Z50518 Z50518 Human Herpesvirus 4 400 0.60 Functional ≤ 10μM
Z50677 Z50677 Human Immunodeficiency Virus 1.8 0.82 Functional ≤ 10μM
Z50607 Z50607 Human Immunodeficiency Virus 1 1.8 0.82 Functional ≤ 10μM
Z50658 Z50658 Human Immunodeficiency Virus 2 2000 0.53 Functional ≤ 10μM
Z80295 Z80295 MT4 (Lymphocytes) 100 0.65 Functional ≤ 10μM
Z100081 Z100081 PBMC (Peripheral Blood Mononuclear Cells) 11.6 0.74 Functional ≤ 10μM

Analogs ( Draw Identity 99% 90% 80% 70% )